SCHEMBL2473376

SCHEMBL2473376

Cc1cccc(NCc2ncc[nH]2)c1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.58
TAAR1 Q96RJ0 7/20 0.54
MAPT P10636 3/20 0.47
GAA P10253 3/20 0.47
TP53 P04637 2/20 0.47
MAPK1 P28482 1/20 0.47
HSD17B10 Q99714 1/20 0.47
LMNA P02545 2/20 0.46
ALDH1A1 P00352 2/20 0.46
KMT2A Q03164 2/20 0.46
PAX8 Q06710 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
KLK1 P06870 1/20 0.42
KLK5 Q9Y337 1/20 0.42
HTR1A P08908 1/20 0.41
ADRA2C P18825 3/20 0.40
TGFBR1 P36897 1/20 0.39
MAPK14 Q16539 1/20 0.39
ADRA2B P18089 1/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2474121 0.83 TAAR1 (0.58) BRD4TAAR1MAPTGAAALDH1A1
SCHEMBL2468823 0.76 BRD4 (0.52) BRD4TAAR1MAPTGAAMAPK1
SCHEMBL3171290 0.75 TAAR1 (0.61) BRD4TAAR1MAPTGAAALDH1A1
SCHEMBL3165410 0.75 TAAR1 (0.61) BRD4TAAR1MAPTGAAHSD17B10
SCHEMBL2471212 0.75 TAAR1 (0.56) BRD4TAAR1MAPTGAAALDH1A1
SCHEMBL2469606 0.75 TAAR1 (0.56) BRD4TAAR1MAPTGAATP53
SCHEMBL3164870 0.74 TAAR1 (0.56) BRD4TAAR1MAPTGAAMAPK1
SCHEMBL6297836 0.74 BRD4 (0.50) BRD4TAAR1MAPTALDH1A1KLK1
SCHEMBL2776944 0.73 TAAR1 (0.68) BRD4TAAR1MAPTGAAALDH1A1
SCHEMBL10885778 0.73 TP53 (0.47) MAPTGAATP53MAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10485786-B2 Pharmaceutical composition for preventing or treating macular degeneration KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2019-11-26 US disclosed
US-20180221343-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MACULAR DEGENERATION KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2018-08-09 US disclosed
EP-2692345-B1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MACULAR DEGENERATION KOREA RES INST CHEMICAL TECH (KR) 2017-07-19 EP disclosed
EP-2692345-A2 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MACULAR DEGENERATION Korea Research Institute Of Chemical Technology (KR) 2014-02-05 EP disclosed
US-20140018402-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MACULAR DEGENERATION Catholic University Industry Academic Cooperation Foundation (KR) 2014-01-16 US disclosed
EP-1546136-B1 BENZOPYRAN DERIVATIVES SUBSTITUTED WITH SECONDARY AMINES INCLUDING IMIDAZOLE, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM KOREA RES INST CHEM TECH (KR) 2011-10-05 EP disclosed
US-20090209422-A1 Insecticidal Substituted Aminoalkyl Heterocyclic and Heteroaryl Derivatives BAYER CROPSCIENCE AG (DE) 2009-08-20 US disclosed
US-20090209422-A1 Insecticidal Substituted Aminoalkyl Heterocyclic and Heteroaryl Derivatives BAYER CROPSCIENCE AG (DE) 2009-08-20 US disclosed
US-20090209422-A1 Insecticidal Substituted Aminoalkyl Heterocyclic and Heteroaryl Derivatives BAYER CROPSCIENCE AG (DE) 2009-08-20 US disclosed
EP-1879455-A1 INSECTICIDAL SUBSTITUTED AMINOALKYL HETEROCYCLIC AND HETEROARYL DERIVATIVES Bayer CropScience AG (DE) 2008-01-23 EP disclosed
US-7279497-B2 Benzopyran derivatives substituted with secondary amines including imidazole, their preparation and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2007-10-09 US disclosed
EP-1546136-A4 BENZOPYRAN DERIVATIVES SUBSTITUTED WITH SECONDARY AMINES INCLUDING IMIDAZOLE, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM KOREA RES INST CHEM TECH (KR) 2007-01-24 EP disclosed
WO-2006119411-A1 INSECTICIDAL SUBSTITUTED AMINOALKYL HETEROCYCLIC AND HETEROARYL DERIVATIVES BAYER CROPSCIENCE AG (DE) 2006-11-09 WO disclosed
US-20050267188-A1 Therapy of cancer, rheumatoid arthritis, and diabetic retinopathies through anti-angiogenic properties, for protection of heart, neuronal cells, brain injury, organs for preservation or in cardiovascular surgery against ischemia-reperfusion injury or oxidative stress KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2005-12-01 US disclosed
EP-1546136-A1 BENZOPYRAN DERIVATIVES SUBSTITUTED WITH SECONDARY AMINES INCLUDING IMIDAZOLE, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Korea Research Institute of Chemical Technology (KR) 2005-06-29 EP disclosed
WO-2004014898-A1 BENZOPYRAN DERIVATIVES SUBSTITUTED WITH SECONDARY AMINES INCLUDING IMIDAZOLE, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2004-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140018402-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MACULAR DEGENERATION PDE6D, PDE6C, PDE6G BRD4 952/4885TAAR1 1079/4885MAPT 442/4885
US-20090209422-A1 Insecticidal Substituted Aminoalkyl Heterocyclic and Heteroaryl Derivatives DDT, AADAC, DDC BRD4 4006/4885TAAR1 162/4885MAPT 4853/4885
US-10485786-B2 Pharmaceutical composition for preventing or treating macular degeneration PDE6D, PDE6C, PDE6G BRD4 952/4885TAAR1 1079/4885MAPT 442/4885
US-20180221343-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MACULAR DEGENERATION PDE6D, PDE6C, PDE6G BRD4 952/4885TAAR1 1079/4885MAPT 442/4885
US-20050267188-A1 Therapy of cancer, rheumatoid arthritis, and diabetic retinopathies through anti-angiogenic properties, for protection of heart, neuronal cells, brain injury, organs for preservation or in cardiovascular surgery against ischemia-reperfusion injury or oxidative stress FLT4, ALDH1A2, KDR BRD4 326/4885TAAR1 4184/4885MAPT 2986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.